Log In
Print
BCIQ
Print
Print this Print this
 

AMAP102

  Manage Alerts
Collapse Summary General Information
Company AnaMar AB
DescriptionInhibitor of interleukin-6 (IL-6) and tumor necrosis factor (TNF) alpha
Molecular Target Interleukin-6 (IL-6) ; Tumor necrosis factor (TNF) alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Interleukin-6 (IL-6) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today